Taken together, this data suggests that the combination of dual PD-1 and CTLA-4 checkpoint inhibition works to inhibit the growth of microsatellite stable murine model of CRC by promoting cytotoxic T cell infiltration and minimizing the impact of the co-inhibitory molecules PD-1 and LAG3. Here, CTLA4 is linked to colorectal carcinoma.